Who’s Going to PepTalk 2027
Jan 18–21, 2027 Carlsbad, CA ~1k attendees Website
231 organizations and 203 speakers at PepTalk 2027, a ~1,000-person, mostly biopharma meeting of protein expression, purification and analytics scientists. As of Oct 29, 2026.
| Organization | PepTalk 2027 Attendance |
|---|---|
AstraZeneca Cambridge, UK | |
Global pharmaceutical company developing antibodies, multispecifics and antibody-drug conjugates across oncology, respiratory, immunology and rare diseases. | Chair Mon Jan 18 8:50am–9:00am Talk Mon Jan 18 9:30am–10:00am Talk Mon Jan 18 11:45am–12:15pm Talk Tue Jan 19 11:20am–11:50am Panel Tue Jan 19 11:50am–12:20pm Chair Tue Jan 19 1:25pm–1:30pm Talk Wed Jan 20 11:10am–11:40am Talk Wed Jan 20 2:30pm–3:00pm Panel Thu Jan 21 7:30am–8:10am Talk Thu Jan 21 9:10am–9:40am Talk Thu Jan 21 11:50am–12:20pm Talk Thu Jan 21 1:40pm–2:00pm Talk Thu Jan 21 2:40pm–3:10pm Panel Thu Jan 21 3:00pm–3:40pm |
Genentech South San Francisco, CA | |
Roche Group biotechnology company discovering and developing antibody, peptide and other protein medicines. | Talk Mon Jan 18 10:00am–10:30am Talk Mon Jan 18 11:45am–12:15pm Talk Mon Jan 18 4:00pm–4:30pm Panel Mon Jan 18 4:30pm–5:00pm Talk Tue Jan 19 11:20am–11:50am De novo Design of Miniprotein Cytokine Mimics Targeting IL4Ra by Combining Diffusion Models, MD Simulations, and Phage Display Predictive and AI-driven protein science Talk Tue Jan 19 2:30pm–3:00pm Panel Tue Jan 19 5:45pm–6:05pm Chair Wed Jan 20 8:15am–8:20am Talk Wed Jan 20 9:40am–10:05am |
Merck & Co. Rahway, NJ | |
Global pharmaceutical company, called MSD outside the US and Canada, with biologics, vaccines and macrocyclic peptide research. | Talk Mon Jan 18 10:00am–10:30am Talk Tue Jan 19 9:10am–9:40am Talk Tue Jan 19 9:40am–10:10am Chair Wed Jan 20 8:30am–8:35am Talk Wed Jan 20 11:10am–11:40am Chair Wed Jan 20 2:25pm–2:30pm Talk Wed Jan 20 3:00pm–3:30pm Talk Wed Jan 20 3:30pm–4:00pm Talk Thu Jan 21 11:50am–12:20pm Talk Thu Jan 21 2:55pm–3:20pm |
Sanofi Paris, France | |
French pharmaceutical company with marketed medicines and vaccines, and biologics research that includes nanobody, multispecific and AI-based protein design. | Talk Mon Jan 18 1:35pm–2:05pm Talk Tue Jan 19 1:30pm–2:00pm Talk Wed Jan 20 8:35am–9:05am Talk Wed Jan 20 3:30pm–4:00pm Chair Thu Jan 21 8:35am–8:40am Chair Thu Jan 21 1:35pm–1:40pm |
Eli Lilly Indianapolis, IN | |
Global pharmaceutical company with peptide, antibody and other medicines in diabetes, obesity, oncology, immunology and neuroscience. | Talk Tue Jan 19 11:50am–12:20pm Panel Tue Jan 19 11:50am–12:20pm Panel Tue Jan 19 4:25pm–5:25pm AI's Real Impact on Biologic Drug Discovery: The Honest Scorecard Predictive and AI-driven protein science Panel Wed Jan 20 1:20pm–2:15pm Peptides at the Inflection Point: From Constrained Scaffolds to AI-Designed Clinical Candidates—Where is Peptide Therapeutics Headed? Peptide discovery and developmentPredictive and AI-driven protein science Talk Wed Jan 20 5:40pm–6:10pm |
Find buyers from companies at PepTalk 2027
Tell us what you sell and we’ll find the people at these companies most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
When and where is PepTalk 2027?
PepTalk 2027 runs January 18–21, 2027, at the Omni La Costa Resort & Spa in Carlsbad, CA.
Where is the PepTalk 2027 program?
This guide lists every organization on the PepTalk 2027 program with its sessions; the full program is on the official website.
How do I register for PepTalk 2027?
Fees and registration are on the organizer's registration page.
What conference is this?
PepTalk is a protein science and production week, held January 18–21, 2027 at the Omni La Costa Resort & Spa in Carlsbad, California. It brings together protein expression, purification, analytics and engineering scientists from biopharma and academia with the instrument, reagent, CRO and software companies that serve them, across tracks and symposia on recombinant protein production, expression platforms, purification and quality, analytical and biophysical methods, automation, display of biologics, multispecifics and T cell engagers, and peptide drug discovery and development.
What is in this guide?
Every organization we can place at PepTalk 2027: 203 speakers from the public agenda (233 talks, panels, roundtables and sponsored presentations) rolled up to their companies and institutions, the 54 exhibitors from the floor plan with their booth numbers, 18 sponsors with their level, and the 185 organizations on the partial attendee list the organizers publish — 231 organizations in one list. Speakers appear as job titles, never by name, and nothing about an individual attendee is shown.
How are organizations typed?
By the role an organization plays in protein science: drug developers (large pharma and biotech), then the companies around them — CROs and CDMOs, discovery platforms, reagent and instrument makers, software and AI companies, and consultancies and other services — and academic, government and non-profit bodies. The topic filters come from the track a talk sits in (both tracks for a joint session); a plenary session's topics are judged from its title.
How current is it?
Pulled from the public track agendas, floor plan, sponsor list and attendee list on October 29, 2026, about 11 weeks before the meeting. The organizers add talks, exhibitors, sponsors and attendees until the meeting, so the lists will grow.
Browse PepTalk 2027 by
Organizations with their own page
108 organizations — every exhibitor and every organization with 2 or more presentations.
- 92Bio
- A-Alpha Bio
- Ab Studio
- AbbVie
- ACROBiosystems
- Agilent
- Aizen Therapeutics
- Alloy Therapeutics
- Amgen
- Apoha
- Arizona State University
- AstraZeneca
- Aureka Biotechnologies
- BigHat Biosciences
- Biofidus
- Biointron
- BioMarin
- Biotage
- BIOVIA
- Boehringer Ingelheim
- Cell Origins
- Cellplus Bio
- Chemical Computing Group
- Chugai Pharmaceutical
- Conigen Bioscience
- Cosmo Bio USA
- Cube Biotech
- Cytiva
- DaltonTx
- Eli Lilly
- ELIQUENT Life Sciences
- EPOC Scientific
- FairJourney Biologics
- Frederick National Laboratory for Cancer Research
- Gator Bio
- GeneFrontier
- Genentech
- Generate Biomedicines
- GenNext Technologies
- GenScript
- Gilead Sciences
- Ginkgo Bioworks
- Harvard Medical School
- Herbert Wertheim UF Scripps Institute
- i3 Membrane
- INFORS HT
- Ingenza
- Institute for Protein Innovation
- Johnson & Johnson Innovative Medicine
- KACTUS
- Kite Pharma
- Lawrence Livermore National Laboratory
- LenioBio
- Liberum Bio
- LifeArc
- Lonza
- Los Alamos National Laboratory
- Malvern Panalytical
- Merck & Co.
- Nabla Bio
- Navigo Proteins
- New England Biolabs
- Nicoya
- Nona Biosciences
- Novartis
- Novo Nordisk
- Novoprotein
- Nuclera
- Ohio State University
- OPM Biosciences
- Orion Pharma
- PAIA Biotech
- Pfizer
- Prescient Design
- Primrose Bio
- ProBio
- ProFound Therapeutics
- PromoChrom Technologies
- ProteoGenix
- Rapid Novor
- Regeneron
- Roche
- Rondo Therapeutics
- Sanofi
- Schrödinger
- Sepia Biosciences
- Septerna
- SPOC Proteomics
- Stanford University
- Synthetic Design Lab
- Tecan
- Teledyne LABS
- Texas Tech University Health Sciences Center
- Thermo Fisher Scientific
- Twist Bioscience
- U.S. Food and Drug Administration
- U.S. Pharmacopeia
- UC Davis
- UCLA
- Unchained Labs
- University of California, Santa Barbara
- University of Florida
- University of Queensland
- University of Surrey
- Vilya
- Vivaproducts
- WuXi Biologics
- Zymeworks
Not affiliated with or endorsed by PepTalk or its organizers. Submit a correction